P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer. (April 2023)

Record Type:: Journal Article
Title:: P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer. (April 2023)
Main Title:: P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer
Authors:: Chien, J.
Esserman, L.
Elias, A.
Wei, M.
Plourde, P.
Portman, D.
Abstract:
Is Part Of:: Breast. Volume 68(2023)Supplement
Journal:: Breast
Issue:: Volume 68(2023)Supplement
Issue Display:: Volume 68, Issue 2023 (2023)
Year:: 2023
Volume:: 68
Issue:: 2023
Issue Sort Value:: 2023-0068-2023-0000
Page Start:: S66
Page End:
Publication Date:: 2023-04
Subjects:: Breast -- Diseases -- Periodicals
Breast -- Tumors -- Periodicals
Breast -- Periodicals
Electronic journals
Periodicals
616
Journal URLs:: http://www.sciencedirect.com/science/journal/09609776 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0960-9776;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/brst/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09609776 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09609776 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0960-9776(23)00249-7 ↗
Languages:: English
ISSNs:: 0960-9776
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2277.492700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 26157.xml